Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes.

Processing-induced transformations (PITs) during pharmaceutical manufacturing are well known but difficult to predict and often difficult to control. This review of the concepts of transformations is couched in terms of the issues associated with identifying rate-controlling events from the materials side and the processing side. Specifically, the approach is reconciling the characteristic time scale of the structural change(s) in the material with the time scale of the processing-induced stress. This is definitely a model (or rather a melding of a group of existing theories) in development. This overview is a 'snapshot' of the authors' attempts to identify the categories of existing theories needed to encompass all of the relevant events for each possible PIT. The ultimate goal is to establish a framework of concepts and theories for consideration, discussion, and modeling of PITs as well as to locate much of the relevant literature in the framework.

[1]  O. Corrigan,et al.  Physicochemical Properties of Spray Dried Drugs: Phenobarbitone and Hydroflumethiazide , 1983 .

[2]  M. Otsuka,et al.  Effect of polymorphic transformation during the extrusion-granulation process on the pharmaceutical properties of carbamazepine granules , 1997 .

[3]  M. Wong,et al.  Physicochemical characterization of a phase change produced during the wet granulation of chlorpromazine hydrochloride and its effects on tableting , 1992 .

[4]  Marek Szafrański,et al.  Structural phase transitions in guanidinium nitrate , 1996 .

[5]  J. Haleblian,et al.  Characterization of habits and crystalline modification of solids and their pharmaceutical applications. , 1975, Journal of pharmaceutical sciences.

[6]  R. Suryanarayanan,et al.  Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets. , 1997, Journal of pharmaceutical sciences.

[7]  F. Rappaport,et al.  Über die Verwendung von Perjodat zur maßanalytischen Bestimmung von Ketosen (Monosacchariden) , 1937 .

[8]  Stephen R. Byrn,et al.  SOLID-STATE ANALYSIS OF POLYMORPHIC, ISOMORPHIC, AND SOLVATED FORMS OF DIRITHROMYCIN , 1994 .

[9]  M. Otsuka,et al.  Relation Between Polymorphic Transformation Pathway During Grinding and the Physicochemical Properties of Bulk Powders for Pharmaceutical Preparations , 1994 .

[10]  C. Eckhardt,et al.  Collective Interactions and Solid State Reactivity , 1998 .

[11]  M. Otsuka,et al.  Effects of grinding on the physicochemical properties of cephalexin powder , 1984 .

[12]  J. Joachim,et al.  Effect of solvate formation on lyoavailability of lorazepam during wet granulation , 1995 .

[13]  N Kaneniwa,et al.  Effect of tabletting on the degree of crystallinity and on the dehydration and decomposition points of cephalexin crystalline powder. , 1985, Chemical & pharmaceutical bulletin.

[14]  M. Otsuka,et al.  Effect of environment on crystallinity and chemical stability in solid-state of ground cephalotin sodium during storage , 1991 .

[15]  N Kaneniwa,et al.  Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. , 1986, Chemical & pharmaceutical bulletin.

[16]  Yoshio Harano,et al.  Growth and Solvent-Mediated Phase Transition of Cimetidine Polymorphic Forms A and B , 1991 .

[17]  D. Turnbull,et al.  Solid State Physics : Advances in Research and Applications , 1978 .

[18]  M. Otsuka,et al.  Effect of Grinding on the Degree of Crystallinity of Cephalexin Powder , 1983 .

[19]  C. Eckhardt,et al.  General Theoretical Concepts for Solid State Reactions: Quantitative Formulation of the Reaction Cavity, Steric Compression, and Reaction-Induced Stress Using an Elastic Multipole Representation of Chemical Pressure , 1995 .

[20]  Christianah Moji Adeyeye,et al.  Evaluation of crystallinity and drug release stability of directly compressed theophylline hydrophilic matrix tablets stored under varied moisture conditions , 1995 .

[21]  K. Sato,et al.  Polymorphic transformations in crystal growth , 1993 .

[22]  Rumi Faizer,et al.  Quantification of crystallinity in blends of lyophilized and crystalline MK-0591 using x-ray powder diffraction , 1995 .

[23]  Bruno C. Hancock,et al.  Characteristics and significance of the amorphous state in pharmaceutical systems. , 1997, Journal of pharmaceutical sciences.

[24]  U J Griesser,et al.  The polymorphic drug substances of the European pharmacopoeia. Part 9. Physicochemical properties and crystal structure of acetazolamide crystal forms. , 1997, Journal of pharmaceutical sciences.

[25]  R. Davey,et al.  The kinetics of solvent-mediated phase transformations , 1985, Proceedings of the Royal Society of London. A. Mathematical and Physical Sciences.

[26]  Bruno C. Hancock,et al.  CHARACTERIZATION OF THE TIME SCALES OF MOLECULAR MOTION IN PHARMACEUTICALLY IMPORTANT GLASSES , 1999 .

[27]  S. Lin,et al.  Polymorphism of spray-dried microencapsulated sulfamethoxazole with cellulose acetate phthalate and colloidal silica, montmorillonite, or talc. , 1981, Journal of pharmaceutical sciences.

[28]  S L Nail,et al.  Effects of freeze-dry processing conditions on the crystallization of pentamidine isethionate. , 1998, Journal of pharmaceutical sciences.

[29]  Otsuka Makoto,et al.  Effect of grinding on the crystallinity and chemical stability in the solid state of cephalothin sodium , 1990 .

[30]  Makoto Otsuka,et al.  Dissolution Behavior of Piretanide Polymorphs at Various Temperatures and pHs , 1995 .

[31]  Y. Kawashima,et al.  Polymorphism and drug release behavior of spray-dried microcapsules of sulfamethoxazole with polysaccharide gum and colloidal silica , 1983 .

[32]  N Kaneniwa,et al.  Effect of compression temperature on the consolidation mechanism of chlorpropamide polymorphs. , 1995, Journal of pharmaceutical sciences.

[33]  M. Otsuka,et al.  Effects of Environmental Temperature and Compression Energy on Polymorphic Transformation During Tabletting , 1993 .

[34]  C. N. R. Rao,et al.  Phase transitions and the chemistry of solids , 1984 .

[35]  N Kaneniwa,et al.  Effect of grinding on the transformations of polymorphs of chloramphenicol palmitate. , 1985, Chemical & pharmaceutical bulletin.

[36]  Makoto Otsuka,et al.  Preparation of Amorphous and Polymorph Piretanide and Their Physicochemical Properties and Solubilities , 1996 .

[37]  J. E. Carless,et al.  The influence of crystal form on the radial stress transmission characteristics of pharmaceutical materials , 1976, The Journal of pharmacy and pharmacology.

[38]  S. McGuigan,et al.  The temperature and pressure dependence of molecular motion in solid naphthalene studied by N.M.R. , 1983 .

[39]  N Kaneniwa,et al.  Effects of the Mechanical Energy of Multi‐tableting Compression on the Polymorphic Transformations of Chlorpropamide , 1989, The Journal of pharmacy and pharmacology.

[40]  S. Byrn Solid state chemistry of drugs , 1982 .

[41]  M. J. Pikal IMPACT OF POLYMORPHISM ON THE QUALITY OF LYOPHILIZED PRODUCTS , 1999 .

[42]  G A Stephenson,et al.  Conformational and color polymorphism of 5-methyl-2-[(2-nitrophenyl) amino]-3-thiophenecarbonitrile. , 1995, Journal of pharmaceutical sciences.

[43]  J. C. Tucker,et al.  Dependence of the glass transition temperature on heating and cooling rate , 1974 .

[44]  A. Burger,et al.  On the polymorphism of pharmaceuticals and other molecular crystals. II , 1979 .

[45]  M. Otsuka,et al.  Effects of crystalline form on the tableting compression mechanism of phenobarbital polymorphs. , 1999, Drug development and industrial pharmacy.

[46]  Peter York,et al.  Binder-substrate interactions in wet granulation. 3: The effect of excipient source variation , 1992 .

[47]  Gérard Coquerel,et al.  Mechanism of Several Solid−Solid Transformations between Dihydrated and Anhydrous Copper(II) 8-Hydroxyquinolinates. Proposition for a Unified Model for the Dehydration of Molecular Crystals , 1996 .

[48]  M. H. Rubinstein,et al.  A Comparison of the Properties of Some Chloramphenicol and Neomycin Eye Ointments, Commercially Available in the U.K , 1983 .

[49]  N Kaneniwa,et al.  Effects of Temperature and Pressure During Compression on Polymorphic Transformation and Crushing Strength of Chlorpropamide Tablets , 1991, The Journal of pharmacy and pharmacology.

[50]  George Zografi,et al.  Assessment of the physical stability of lyophilized MK-0591 by differential scanning calorimetry , 1996 .

[51]  Kenneth R. Morris,et al.  Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development , 1994 .

[52]  K R Morris,et al.  Solid-state NMR and IR for the analysis of pharmaceutical solids: polymorphs of fosinopril sodium. , 1993, Journal of pharmaceutical and biomedical analysis.

[53]  Jouko Yliruusi,et al.  The effect of fluidized bed granulation on the crystal properties of lactose, glucose and mannitol , 1996 .

[54]  Helga Doser Über die Schmelzpunkte des Pantokains, Bromurals und Theophyllins , 1943 .

[55]  A W Malick,et al.  Stability of a hydrophobic drug in presence of hydrous and anhydrous lactose. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[56]  J. Remon,et al.  Formation of theophylline monohydrate during the pelletisation of microcrystalline cellulose-anhydrous theophylline blends , 1988 .

[57]  H. Brittain,et al.  EFFECTS OF PHARMACEUTICAL PROCESSING ON DRUG POLYMORPHS AND SOLVATES , 1999 .

[58]  H. Callen Thermodynamics and an Introduction to Thermostatistics , 1988 .

[59]  N Kaneniwa,et al.  Effect of seed crystals on solid-state transformation of polymorphs of chloramphenicol palmitate during grinding. , 1986, Journal of pharmaceutical sciences.

[60]  E. Suzuki,et al.  Thermochemical Study of Theophyline and Its Hydrate , 1989 .

[61]  Eric Doelker,et al.  Polymorphic Transformation of Some Drugs Under Compression , 1985 .

[62]  Makoto Otsuka,et al.  Preparation of Piretanide Polymorphs and Their Physicochemical Properties and Dissolution Behaviors , 1994 .

[63]  H. Ohtani,et al.  Effect of Humidity on Solid‐state Isomerization of Various Kinds of Lactose During Grinding , 1993, The Journal of pharmacy and pharmacology.

[64]  S. K. Sikka,et al.  High pressure phase transitions in organic solids I:α → β transition in resorcinol , 1985 .

[65]  Makoto Otsuka,et al.  Physicochemical Characterization of Phenobarbital Polymorphs and Their Pharmaceutical Properties , 1994 .

[66]  H. Brittain Polymorphism in Pharmaceutical Solids , 1999 .

[67]  O. Levenspiel,et al.  Fluidization engineering, 2nd edition , 1991 .

[68]  M. Otsuka,et al.  Effect of Environmental Temperature on the Polymorphic Transformation of Phenylbutazone during Grinding , 1988 .

[69]  Yoshiteru Takahashi,et al.  Polymorphism of Fostedil: Chracterization and Polymophic Change by Mechanical Treatments , 1985 .

[70]  M. Otsuka,et al.  X-Ray Powder Diffraction Study on the Grinding Effect of the Polymorphs of a Novel and Orally Effective Uricosuric Agent: FR76505 , 1994 .